— Know what they know.
Not Investment Advice

VCNX Earnings

Vaccinex, Inc.
1W: +4.1% 1M: +1.0% 3M: -9.8% YTD: -10.6% 1Y: +62.9% 3Y: -93.6% 5Y: -99.8%
$1.01
+0.01 (+1.00%)
 
Weekly Expected Move ±22.3%
$1 $1 $1 $1 $1
OTC · Healthcare · Biotechnology · Tech Score Buy · Power 66 · $2.7M mcap · 1M float · 0.163% daily turnover · Short 56% of daily vol
Last Earnings 2026-05-18
EPS
$-2.94
▼ Miss +0.0%
Revenue
$104K
▲ Beat +0.0%
Next Earnings 2026-11-16
EPS Estimate
$-60.90
Range: $-60.90 - $-60.90
Revenue Estimate
$355K
1 analysts

Estimate vs Actual

Earnings Surprise History

0/5
EPS Beats
0/5
Revenue Beats
0%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-01 quarter 2027-06-30 $-56.70 $-63.00 ▼ 6.30 $403,654 $403,654
2026-10-01 quarter 2028-09-30 $-63.29 $-63.36 ▼ 0.07 $555,680 $555,680
2026-10-01 quarter 2028-12-31 $-54.77 $-63.29 ▼ 8.52 $592,363 $592,363
2026-10-01 quarter 2029-06-30 $-54.77 $-48.28 ▲ 6.49 $673,153 $673,153
2026-10-01 quarter 2028-06-30 $-63.36 $-56.57 ▲ 6.79 $521,269 $521,269
2026-10-01 quarter 2027-03-31 $-63.00 $-60.90 ▲ 2.10 $378,657 $378,657
2026-10-01 quarter 2028-03-31 $-56.57 $-56.70 ▼ 0.13 $488,988 $488,988
2026-10-01 quarter 2026-09-30 $-60.90 $-73.04 ▼ 12.14 $333,212 $333,212
2026-10-01 quarter 2029-03-31 $-48.28 $-54.77 ▼ 6.49 $631,467 $631,467
2026-07-30 quarter 2020-09-30 $— $-101.44 ▼ 101.44 $— $630,000
2026-07-30 annual 2018-12-31 $— $-761.25 ▼ 761.25 $— $616,667
2026-07-30 quarter 2021-09-30 $— $-60.90 ▼ 60.90 $— $445,192
2026-07-30 annual 2020-12-31 $— $-327.60 ▼ 327.60 $— $600,000
2026-07-30 annual 2019-12-31 $— $-557.55 ▼ 557.55 $— $566,000
2026-07-30 annual 2021-12-31 $— $-239.40 ▼ 239.40 $— $900,000
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms